Results 71 to 80 of about 3,978,530 (165)
Researchers’ Experiences with IRB Oversight of Psychedelic Research
ABSTRACT Previous research raises concern that conservative institutional review board (IRB) approaches regarding stigmatized issues and vulnerable groups could similarly arise as an impediment to research with psychedelic drugs. We interviewed 20 US researchers who had been a principal investigator on at least one research protocol involving ...
Logan Neitzke‐Spruill +5 more
wiley +1 more source
Obsessive–Compulsive Disorder: Comorbidity, Biomarkers, Circuits, and Treatment Strategies
OCD has a high comorbidity with other psychiatric conditions, among which anxiety is the most frequent one. The shared genetic biomarkers and common neural circuits underlying the co‐occurrence of OCD and anxiety pave a new path for understanding the pathogenic mechanism of OCD and suggest tailored and integrative treatment therapies for OCD from the ...
Xiao‐Yang Zhang +9 more
wiley +1 more source
Lysergic acid diethylamide (LSD) induces transcriptional programmes in the rodent prefrontal cortex that oppose signatures of human brain ageing and neurodegeneration. In primary cortical cultures, LSD also attenuates amyloid‐β‐induced alterations. Consistent with the signature reversion principle, these findings provide a data‐driven rationale for ...
Aurora Savino +9 more
wiley +1 more source
ABSTRACT Introduction Psilocybin is a naturally occurring classic psychedelic associated with widespread changes in brain function and promising therapeutic outcomes in several neuropsychiatric disorders. Complementing these findings, qualitative studies following psilocybin administration have revealed diverse and highly individual effects across ...
Ruiqi Rachel Luo +5 more
wiley +1 more source
Narrative therapy-assisted psilocybin use for treatment of depression
There is recent renewed interest in use of psychedelic drugs for treatment of psychiatric disorders, including serotonin agonists such as psilocybin, potentially providing a new approach to treatment.
Delavan, Carlyn
core
Background: Healthcare workers experienced amplified depression and burnout during COVID-19. Both Mindfulness Based Stress Reduction (MBSR) and psilocybin have been shown to reduce depressive symptoms in this population, however the psychological ...
Kevin Byrne +3 more
doaj +1 more source
Abstract Human binge eating disorder is characterized by recurrent episodes of excessive food consumption accompanied by loss of control and is strongly associated with alterations in reward processing and emotional regulation. Ayahuasca, a psychoactive botanical preparation traditionally used in Amazonian medicine, has been shown to modulate ...
Cristian Ferreira Corona +10 more
wiley +1 more source
OBJECTIVE: This study invited providers who care for patients with eating disorders to inform engagement, communication, and collaboration with psilocybin-assisted psychotherapy interventions.
Amanda E. Downey +12 more
core +1 more source
BackgroundPosttraumatic stress disorder (PTSD) affects 3.9% of the general population. While massed cognitive processing therapy (CPT) has demonstrated efficacy in treating chronic PTSD, a substantial proportion of patients still continue to meet PTSD ...
Shakila Meshkat +7 more
doaj +1 more source
Psilocybin-assisted psychotherapy represents a promising addition to palliative care interventions, potentially improving quality of life by addressing existential distress.
Michel Dorval +11 more
doaj +1 more source

